It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

The majority of strokes could be prevented, according to new guidelines aimed at helping people and their doctors do just ...

We got some good news from the poor old entertainment companies this earnings season. Video streaming is finally becoming a ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have wide-reaching implications for the nation’s health and medical costs as it faces a ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...